Free Trial

Nuvectis Pharma (NVCT) Earnings Date, Estimates & Call Transcripts

Nuvectis Pharma logo
$4.90 -0.17 (-3.35%)
(As of 02:00 PM ET)

Nuvectis Pharma Latest Earnings Summary

Upcoming Q4
Earnings Date
Mar. 4Estimated
Actual EPS
(Nov. 5)
-$0.24 Beat By $0.01
Consensus EPS
(Nov. 5)
-$0.25

Nuvectis Pharma announced Q3 2024 earnings on November 5, 2024, reporting an EPS of -$0.24, which topped the consensus estimate of -$0.25 by $0.01. With a trailing EPS of -$1.16, Nuvectis Pharma's earnings are expected to grow next year, from ($1.01) to ($0.95) per share.

NVCT Upcoming Earnings

Nuvectis Pharma's next earnings date is estimated for Tuesday, March 4, 2025, based off prior year's reporting schedules.

Get Nuvectis Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nuvectis Pharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

NVCT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NVCT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Nuvectis Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.41-$0.39-$0.40
Q2 20242-$0.29-$0.23-$0.26
Q3 20242-$0.26-$0.25-$0.26
Q4 20242-$0.31-$0.25-$0.28
FY 20248-$1.27-$1.12-$1.20
Q1 20251-$0.23-$0.23-$0.23
Q2 20251-$0.22-$0.22-$0.22
Q3 20251-$0.23-$0.23-$0.23
Q4 20251-$0.23-$0.23-$0.23
FY 20254($0.91)($0.91)($0.91)

Nuvectis Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/4/2025
(Estimated)
------- 
11/5/2024Q3 2024-$0.25-$0.24+$0.01-$0.24--
8/6/2024Q2 2024-$0.26-$0.26--$0.26--
5/7/2024Q1 2024-$0.40-$0.25+$0.15-$0.25--  
3/5/2024Q4 2023-$0.40-$0.41 -$0.01-$0.41--  
11/8/2023Q3 2023-$0.38-$0.37+$0.01-$0.37--  
8/9/2023Q2 2023-$0.34-$0.38 -$0.04-$0.38--  
5/10/2023Q1 2023-$0.44-$0.27+$0.17-$0.27--  
3/7/2023Q4 2022-$0.36-$0.48 -$0.12-$0.48--  

Nuvectis Pharma Earnings - Frequently Asked Questions

Nuvectis Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based off last year's report dates. Learn more on NVCT's earnings history.

In the previous quarter, Nuvectis Pharma (NASDAQ:NVCT) reported ($0.24) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.25) by $0.01. Learn more on analysts' earnings estimate vs. NVCT's actual earnings.

Nuvectis Pharma (NASDAQ:NVCT) has a recorded net income of -$22.26 million. NVCT has generated -$1.16 earnings per share over the last four quarters.

Nuvectis Pharma's earnings are expected to grow from ($1.01) per share to ($0.95) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:NVCT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners